Form 4: Amedisys Director Paul B. K. Kusserow Receives Stock Award

Director Paul B. K. Kusserow of Amedisys Inc. was awarded 1,678 restricted stock units that will vest on May 3, 2025, contingent upon continued service on the Board of Directors.

Summary

• Paul B. K. Kusserow, a director at Amedisys Inc. (AMED), received 1,678 time-based Restricted Stock Units (RSUs) on May 3, 2024.
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2025, provided Kusserow continues to serve as a non-employee member of the Issuer's Board of Directors through that date.
• Following the transaction, Kusserow directly owns 353,670 shares of Amedisys common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.

Positives

• The award of restricted stock units aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for incentivizing board members.

Comparison to Industry Standards

• Granting restricted stock units to board members is a common practice among publicly traded companies to align their interests with those of shareholders.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also utilize stock-based compensation for their directors.
• The vesting schedule of one year is fairly standard, ensuring continued commitment from the director.

Stakeholder Impact

• The stock award aligns the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.

Key Dates